"Relaro Medical Trials is a fully dedicated, multidisciplinary research clinic that specializes in phases II through IV clinical trials in various therapeutic areas, primarily Psychiatry. Our team consists of highly skilled medical professionals with over 43 years in clinical research experience combined. We value our patient volunteers and their contributions to the advancement of medicine. Advancing and improving medicine with integrity and quality, while reducing the stigma of clinical research. We see our patients as human beings and focus on building trust while serving as a resource to the community."

During the past decade, Relaro Medical Trials conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Relaro Medical Trials" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 3 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Emalex Biosciences Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Relaro Medical Trials" #1 collaborator was "Innovis LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Relaro Medical Trials" are "Depressive Disorder, Major" (4 trials), "Anxiety" (1 trials), "Attention Deficit Hyperactivity Disorder" (1 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials) and "Autism Spectrum Disorder" (1 trials). Many other conditions were trialed in "Relaro Medical Trials" in a lesser frequency.

Most popular intervention types in "Relaro Medical Trials" are "Drug" (17 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Rapastinel" (3 trials), "Ecopipam" (2 trials), "Brexpiprazole" (1 trials) and "Esketamine 56 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Relaro Medical Trials" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Relaro Medical Trials". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Relaro Medical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Relaro Medical Trials, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".